Researchers have been excited about this new drug, a novel dual compound showing promising data in early trials for weight loss . It acts by targeting both pathways : GLP-1 and GIP, which , when https://pennyoewk132842.yomoblog.com/48027248/this-new-hope-for-body-reduction